SK bioscience

본문바로가기

KOR ENG

sitemap

PR

SK bioscience company news updates

Press Releases

SK bioscience-Novavax Sign CDMO of COVID-19 Vaccine Agreement with Novavax

2020. 08. 14
SK biosciences Underwriters for IPO Promotion

2020. 07. 26
SK bioscience - Ministry of Health and Welfare - AstraZeneca Agree Trilateral Partnership for Cooperation for Global Supply of the COVID-19 Vaccine

2020. 07. 21
SK bioscience’s Quadrivalent Influenza Vaccine Achieved Approval by the Ministry of Food and Drug Safety for Infant Use

2020. 06. 23
SK bioscience Receives Fund for COVID-19 Vaccine Development

2020. 05. 18
SK bioscience-Sanofi Pasteur Suubmit IND Amendment for Phase II Global Clinical Trial of Next-Generation Pneumococcal Conjugate Vaccine

2020. 03. 30
SK biosicnece Enters Animal Testing Stage Of COVID-19 Vaccine

2020. 03. 24
SK bioscience Is Chosen As Partner for National Project of Developing COVID-19 Vaccine Candidate

2020. 03. 18
SK bioscience´s Shingles Vaccine Sales Exceed 1 Million Doses Two Years After Launch

2020. 03. 12
SK bioscience Initiates Development of New Vaccine Platform Against Vartiants in Response to New Infectious Diseases

2020. 02. 24
SK bioscience Receives WHO PQ of Cell Culture-Based Quadrivalent Influenza Vaccine

2020. 01. 02
SK bioscience’s Varicella Vaccine Obtains World’s 2nd WHO PQ Certification

2019. 12. 11